USPTO serial 79402309
SEAMLESS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 17, 2026
- Examiner
- LIU, PHILIP
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SEAMLESS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Brian J. Focarino
Brian J. Focarino COOLEY LLP1299 Pennsylvania Ave. NW STE 700Washington, DC 20004United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry and science; biological preparations and biological chemical reagents for use in industry and science; all of the foregoing used for non-medical purposes | ACTIVE | — |
| 005 | Pharmaceutical and biological preparations for gene therapies and gene-editing therapies, all for the treatment of genetic and viral diseases; medical, pharmaceutical and biopharmaceutical preparations and substances containing programmable recombinases for the treatment of genetic and viral diseases; pharmaceutical goods and preparations, namely, gene transfer, regulation, modulation and delivery medications for the treatment of genetic and viral diseases and disorders; products, agents, for medical purposes, for veterinary purposes in the nature of pharmaceutical preparations for cellular, genome and gene editing therapies to treat genetic, oncological, immune system-related, and inflammatory disorders and diseases; genome editable enzymes being enzymes for medical purposes; DNA recombinant enzymes being enzymes for medical purposes; DNA editable enzymes, especially, recombinases and integrases being enzymes for medical purposes; genome editable enzymes for the treatment of diseases being enzymes for medical purposes; DNA recombinant enzymes for the treatment of diseases being enzymes for medical purposes; DNA editable enzymes, in particular recombinases and integrases, for the treatment of diseases being enzymes for medical purposes | ACTIVE | — |
| 042 | Scientific and technological services, namely, product research and testing of pharmaceuticals for cell and gene therapies in the field of pharmaceutical product development for the creation of bioinformatic algorithms and models; development of pharmaceutical preparations and medicines, none of the foregoing for diagnostics; pharmaceutical product development, none of the foregoing for diagnostics; pharmaceutical products development of genome editable enzymes for treatment and not diagnostic purposes; pharmaceutical products development of DNA editable enzymes, in particular recombinases and integrases, for treatment and not diagnostic purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Seamless Therapeutics GmbH
- Other trademarks owned by Seamless Therapeutics GmbH
- Other trademarks owned by Seamless Therapeutics GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named SEAMLESS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 10, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 21, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 21, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 25, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 17, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 19, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 19, 2026 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Mar 19, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 19, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 17, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 17, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 29, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 27, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 27, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 21, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 14, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 14, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 30, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 30, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 30, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 30, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 30, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 30, 2025 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Dec 22, 2025 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Dec 22, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 22, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 22, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 22, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 22, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 22, 2025 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Nov 10, 2025 | GEA1 | NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED | — |
| Nov 10, 2025 | GECD | ACTION DENYING REQ FOR RECON E-MAILED | — |
| Nov 10, 2025 | CNCF | ACTION CONTINUING FINAL - COMPLETED | — |
| Oct 27, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 27, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 27, 2025 | ALIE | ASSIGNED TO LIE | — |
| Oct 20, 2025 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Oct 20, 2025 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Oct 20, 2025 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Oct 20, 2025 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Apr 19, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 19, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 19, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 7, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 7, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 7, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 30, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 7, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 7, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 4, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 3, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 22, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 21, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 21, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 15, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |